Cardiology Clinical guideline

Persistent Pulmonary Hypertension (PPHN)

Presentation

  • Cyanosis disproportionate to degree of respiratory distress
  • Pre-ductal vs post-ductal SpO2 saturation gradient > 5%
  • Prominent apical impulse or tricuspid regurgitation murmur
  • Labile oxygenation

Initial Workup

  • Pre and post-ductal pulse oximetry
  • Arterial blood gases
  • Chest X-ray to assess underlying parenchymal lung disease
  • Echocardiogram (essential to rule out structural congenital heart disease)

Diagnostic Criteria

  • Echocardiographic evidence of right-to-left or bidirectional shunting
  • Elevated pulmonary artery pressure estimates (TR jet velocity)
  • Structurally normal heart (excluding PFO/PDA)

Extended Pharmacology & Critical Care

  • Alprostadil (PGE1) continuous infusion: Start at 0.05 to 0.1 mcg/kg/min; monitor strictly for apnea, hyperthermia, and extreme vasodilation.
  • Milrinone loading dose 50 mcg/kg over 15 mins (only if stable blood pressure), followed by 0.33 to 0.75 mcg/kg/min infusion.
  • Strict I&O monitoring; maintain urine output > 1-2 mL/kg/hr using indwelling catheter if necessary.
  • Maintain hematocrit > 35-40% via PRBC administration to optimize oxygen delivery in cyanotic lesions.
  • Nursing: Q1 hour blood pressure monitoring (arterial line preferred), monitor for feeding intolerance indicating gut hypoperfusion.

Standardized Discharge & Follow-Up Criteria

  • Adequate weight gain explicitly > 15-30g/day over a continuous 3-5 day period.
  • Maintenance of temperature in an open crib with standard clothing for 48 hours.
  • Successful completion of the 90-120 minute Infant Car Seat Challenge.
  • Caregiver successfully completed CPR training, rooming-in, and independent medication administration.
  • Referrals placed for High-Risk Infant Follow-Up Clinic, Early Intervention (PT/OT), and appropriate sub-specialists.

Diagnostic & Management Algorithm

  • PPHN Targeted Reversal: [START] Severe Hypoxemia + Echo R->L shunt -> [ACTION] Optimize lung recruitment / reverse acidosis -> [PHARMACOLOGY] Inhaled Nitric Oxide (iNO) 20ppm -> [EVALUATE] Oxygenation index (OI) > 40? -> [YES] ECMO

References

  1. Nair J, Lakshminrusimha S. Update on PPHN: Mechanisms and treatment. Semin Perinatol.
  2. Konduri GG. New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol.

Medical disclaimer: This page is for qualified healthcare professionals and is a decision-support aid only. It does not replace clinical judgement, local protocols or product information. Verify every dose and threshold before use. See the full Medical Disclaimer.